• Explore /
  • Poster
  • / Evaluation of cardiovascular risk in patients with prostate cancer initiating novel hormonal therapy.

Evaluation of cardiovascular risk in patients with prostate cancer initiating novel hormonal therapy.

Abstract Poster

Authors

null

Michael F. Sayer

University of California, Irvine, Irvine, CA

Michael F. Sayer , Aya Ozaki , Dalia Kaakour , Eunah Cho , Pamela Maree Di Tomasso , Ali Naqvi , Bahman Farihi , Bjorn D. Manansala , Pranav M. Patel , Nataliya Mar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Patient Safety

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 301)

DOI

10.1200/OP.2024.20.10_suppl.301

Abstract #

301

Poster Bd #

F15

Abstract Disclosures

Similar Posters

First Author: Jian Guan

First Author: Evan Y. Yu

First Author: Brent Cao

First Author: Alicia K. Morgans